| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169438A1 Pcr-based cloning method |
| 01/09/2002 | EP1169437A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology |
| 01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169330A2 Information-carrying and information-processing polymers |
| 01/09/2002 | EP1169123A1 Encoding scheme for solid phase chemical libraries |
| 01/09/2002 | EP1169066A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 01/09/2002 | EP1169058A1 Insulin-like growth factor binding protein-4 protease |
| 01/09/2002 | EP1169054A2 Products and methods for treating ptp lar related diseases |
| 01/09/2002 | EP1169049A2 Treatment of myeloma bone disease with proteasomal and nf-kappa-b activity inhibitors |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | EP1168924A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1023459A4 Determination of cyclin-dependent kinase inhibitor p27 levels as a prognostic factor in cancer patients |
| 01/09/2002 | EP1017841A4 Chromatographic method for mutation detection using mutation site specifically acting enzymes |
| 01/09/2002 | EP0984978A4 Band array display of polynucleotide separations |
| 01/09/2002 | EP0873354A4 Novel amp activated protein kinase |
| 01/09/2002 | EP0832281B1 Method for detecting nucleic acid sequences using competitive amplification |
| 01/09/2002 | EP0725149B1 Method of detecting nucleic acid |
| 01/09/2002 | EP0716714B1 Oligonucleotides and methods for the detection of Chlamydia trachomatis |
| 01/09/2002 | EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 01/09/2002 | CN2470824Y Quick-acting detecting instrument for microorganism contained in grain in storage |
| 01/09/2002 | CN2470367Y Gene increasing, hybridizing detection integrated reaction tube cap |
| 01/09/2002 | CN2470366Y Biological chip |
| 01/09/2002 | CN1330768A Biofouling monitor and method to monitoring or detect biofouling |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330713A Zinc finger binding domains for GNN |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330663A Hypoxia-inducible factor I-alpha HIF-I-alpha variants and methods for identifying HIF-I-alpha modulators |
| 01/09/2002 | CN1330155A Membrane transfer method for testing gene chip |
| 01/09/2002 | CN1330154A Cell microarray chip and its preparing process |
| 01/09/2002 | CN1330153A Pylorospirobacillus antigen in blood |
| 01/09/2002 | CN1330151A Flow-type cell instrument based on microflow control technique |
| 01/09/2002 | CN1330146A Polypeptide-human dynein receptor-similar kinase 43 and polynucleotide for coding it |
| 01/08/2002 | US6337393 Reducing liquid evaporation during solid phase micro-scale synthesis on an open environment solid support surface; the liquid reagent is a solvent with a high boiling point to prevent evaporation while maintaining a high reaction yield |
| 01/08/2002 | US6337391 Polycation-sensing receptor in aquatic species and methods of use |
| 01/08/2002 | US6337386 Toxin Assay |
| 01/08/2002 | US6337214 Detection of DNA, RNA and proteins using a test column with two snares |
| 01/08/2002 | US6337207 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 01/08/2002 | US6337202 Genes encoding several poly (ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith |
| 01/08/2002 | US6337188 Sequencing a template without prior knowledge of the sequence in conjunction with primer extension in the presence of a labeled chain terminating nucleotide using a reagent having a capture moeity, a spacer region and hybridizing region |
| 01/08/2002 | US6337187 An isolated nucleic acid molecule; diagnosis and therapy for obesity, hypertriglyceridemia, and atherosclerosis |
| 01/08/2002 | US6337185 Method of sequencing |
| 01/08/2002 | US6337184 Detecting expression of a gene operatively linked to bcl-2, an apoptosis inhibition protein, within myogenic cells, as an indication the the myogenic cell is a muscle stem cell |
| 01/08/2002 | US6337183 Screen for compounds with affinity for nucleic acids |
| 01/08/2002 | US6337182 Method for the quantitative determination of DNA sequences |
| 01/08/2002 | US6337178 Quantitative analysis; measuring electrode potential |
| 01/08/2002 | US6337088 Selecting a bacteriophage having dimensions similar to virus; loading bacteriophage into jacket comprising hollow fiber, sealing top and bottom ends, placing jacket into bath solution, inoculating lawn of bacteria, calculating retention |
| 01/08/2002 | CA2286287C Hybridisation assay in which excess probe is destroyed |
| 01/08/2002 | CA2246222C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/08/2002 | CA2165821C Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/08/2002 | CA2126391C Determination of nucleic acid by pcr, measurement of number of microbial cells, genes, or gene-copies by pcr, and measuring-kit employed for the same |
| 01/08/2002 | CA2116560C Morphogenic protein screening method |
| 01/07/2002 | CA2582179A1 Methods for identifying combinations of entities as therapeutics |
| 01/03/2002 | WO2002001412A1 Microbe analyzing system and method, and database |
| 01/03/2002 | WO2002001230A2 Rapid and sensitive detection of protein aggregation |
| 01/03/2002 | WO2002001228A2 Interaction of colloid-immobilized species with species on non-colloidal structures |
| 01/03/2002 | WO2002000939A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/03/2002 | WO2002000938A2 Methods and compositions for transcription-based nucleic acid amplification |
| 01/03/2002 | WO2002000936A1 Method for automated molecular cloning |
| 01/03/2002 | WO2002000935A1 Method for predicting drug clearance and individualized dosage |
| 01/03/2002 | WO2002000934A2 Multiply-primed amplification of nucleic acid sequences |
| 01/03/2002 | WO2002000933A2 Screening assays for identifying modulators of the inflammatory or immune responses |
| 01/03/2002 | WO2002000932A2 Diagnosis of known genetic parameters within the mhc |
| 01/03/2002 | WO2002000931A2 Sample generation for genotyping by mass spectrometry |
| 01/03/2002 | WO2002000930A2 Method for dna extraction |
| 01/03/2002 | WO2002000929A1 Method for in vitro diagnosis of prostatic cancer and kit therefor |
| 01/03/2002 | WO2002000928A2 Diagnosis of diseases associated with the immune system by determining cytosine methylation |
| 01/03/2002 | WO2002000927A2 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 01/03/2002 | WO2002000926A2 Diagnosis of diseases associated with signal transduction |
| 01/03/2002 | WO2002000925A1 Method for monitoring the effect of cancer therapies |
| 01/03/2002 | WO2002000924A2 Viral phospholipase a2 enzymes, anti-viral agents and methods of use |
| 01/03/2002 | WO2002000923A1 Methods for identifying inhibitors of the anaphase promoting complex |
| 01/03/2002 | WO2002000922A1 Vibrio bacteria detection and/or differentiation |
| 01/03/2002 | WO2002000921A1 Nutritional mixture and method for early identification and count of gram-negative organisms |
| 01/03/2002 | WO2002000919A2 Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring |
| 01/03/2002 | WO2002000918A2 Biosensor and method for production thereof |
| 01/03/2002 | WO2002000915A2 Cyanobacterial nucleic acid fragments encoding proteins useful for controlling plant traits via nuclear or plastome transformation |
| 01/03/2002 | WO2002000913A2 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2 |
| 01/03/2002 | WO2002000904A2 Recombinant constructs and their use in reducing gene expression |
| 01/03/2002 | WO2002000902A2 Regulation of anthocyanin pigment production |
| 01/03/2002 | WO2002000897A2 Novel chimeric promoters |
| 01/03/2002 | WO2002000887A1 Novel therapeutic molecular variants and uses thereof |
| 01/03/2002 | WO2002000876A1 Truncated egf receptor |
| 01/03/2002 | WO2002000873A1 Human site-1 protease promoter |
| 01/03/2002 | WO2002000871A2 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
| 01/03/2002 | WO2002000860A2 Novel proteases |
| 01/03/2002 | WO2002000848A1 Dna/rna-embedding medium and method of use |
| 01/03/2002 | WO2002000842A2 Methods for isolating centromere dna |
| 01/03/2002 | WO2002000840A2 Human lyases |
| 01/03/2002 | WO2002000730A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000727A2 Gp286 nucleic acids and polypeptides |